Perrigo Changes Reporting Structure In Latest Stop On Cost-Cutting Trail
Executive Summary
Perrigo reorganizes its reporting segments to better align with its organizational structure; consumer product units are combined and renamed.
You may also be interested in...
Starboard Agreement Tilts Perrigo Toward Rx Generics Sale
OTC private label giant agrees with Starboard, which owns around 6.7% of Perrigo's shares, to immediately add to Perrigo's board Starboard CEO Jeffrey Smith and two other members recommended by the hedge fund: former Pfizer CEO Jeffrey Kindler and Nestle USA executive Bradley Alford.
Starboard Agreement Tilts Perrigo Toward Rx Generics Sale
OTC private label giant agrees with Starboard, which owns around 6.7% of Perrigo's shares, to immediately add to Perrigo's board Starboard CEO Jeffrey Smith and two other members recommended by the hedge fund: former Pfizer CEO Jeffrey Kindler and Nestle USA executive Bradley Alford.
Perrigo Starts Branded Consumer Product Rescue Mission In Belgium
Perrigo is restructuring its OTC drug and nutritional product businesses in Belgium – Omega Pharma Belgium NV, Etixx NV and Biover NV – and expects changes will eliminate between 45 and 80 jobs.